South Korea
SNB-101 showed excellent efficacy in animal small cell lung cancer models, and based on this, it has been designated as an orphan drug by the US FDA after ...
July 21, 2023 | News
Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social an...
July 19, 2023 | News
Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...
July 18, 2023 | News
SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutti...
July 18, 2023 | News
□ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...
July 11, 2023 | News
To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...
July 10, 2023 | News
Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...
July 07, 2023 | News
Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...
July 06, 2023 | News
SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...
July 05, 2023 | News
Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of ...
July 04, 2023 | News
The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...
July 03, 2023 | News
SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...
June 27, 2023 | News
The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nerv...
June 27, 2023 | News
84% ORR (32 of 38 patients) and 71% CR (27 of 38 patients) documented after 2 million cells/kg dose anbal-cel treatment to patients in relap...
June 20, 2023 | News
Most Read
Bio Jobs
News
Editor Picks